<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04648579</url>
  </required_header>
  <id_info>
    <org_study_id>HILLROM</org_study_id>
    <nct_id>NCT04648579</nct_id>
  </id_info>
  <brief_title>Automated Documentation of Vital Parameters Using Mobile Stations and Activation of the Rapid Response Team</brief_title>
  <official_title>Automated Documentation of Vital Parameters in Wards Using Mobile Stations - Effect on the Appropriate Activation of the Rapid Response Team: a Cluster Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital do Coracao</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital do Coracao</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The documentation of vital signs is traditionally performed manually when the patient is not&#xD;
      admitted in intensive care units, which can lead to documentary errors, long time for data&#xD;
      acquisition and, consequently, impairment in the early identification of possible clinical&#xD;
      deterioration. In-bed technology solutions are available to automate the collection of vital&#xD;
      data and transfer information to a medical record or central electronic monitoring and its&#xD;
      role in the health value chain needs further investigation. The investigators propose to&#xD;
      evaluate the impact of the Connex Spot Monitor solution Welch Allyn (CSM / Hillrom) in&#xD;
      conjunction with the Hillrom Connecta solution in a real world situation, conducting a&#xD;
      cluster randomized trilal in wards of a tertiary hospital. In addition, this study aims to&#xD;
      estimate the clinical effectiveness of a technological solution that performs an analysis of&#xD;
      vital signs and automatically activates the rapid response team (RRT) when the pre-defined&#xD;
      criteria are met, comparing it with the traditional manual method. The primary outcome is the&#xD;
      number of times that the RRT fires in a timely manner.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 22, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>RRT</measure>
    <time_frame>24 hours</time_frame>
    <description>Number of rapid response team triggers activated in a timely manner.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">216</enrollment>
  <condition>Inpatient Facililty Diagnoses</condition>
  <arm_group>
    <arm_group_label>Hillrom</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention involves an automated vital signs document system consisting of a mobile medical device for measuring vital signs (CSM / Hillrom) that collects and analyzes data acquired at the bedside to be sent to a remote data processing point (Digital Control Station), using Hillrom Connecta software.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Hospital usual care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hillrom</intervention_name>
    <description>Hillrom Connecta solution will record vital signs in an automated way, without the need for human intervention, and activate TRR activation when at least one criteria is met. The frequency of monitoring vital signs will be defined based on the MEWS score.</description>
    <arm_group_label>Hillrom</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Hospital usual care regarding vital signs collection and TRR activation.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - All patients with activated RRT during the study recruitment period.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  COVID-19 diagnosis;&#xD;
&#xD;
          -  individuals who need blood pressure measured in lower members.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>José César Ribeiro, RN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital do Coracao</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>José César Ribeiro, RN</last_name>
    <phone>+551130536611</phone>
    <phone_ext>1066</phone_ext>
    <email>jribeiro@hcor.com.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital do Coracao</name>
      <address>
        <city>São Paulo</city>
        <state>Sao Paulo</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José Cesar Ribeiro, RN</last_name>
    </contact>
    <contact_backup>
      <last_name>Cristina Sgorbissa, RN</last_name>
    </contact_backup>
    <investigator>
      <last_name>Aline Marcadenti, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexandre B Cavalcanti, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 23, 2020</study_first_submitted>
  <study_first_submitted_qc>November 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 1, 2020</study_first_posted>
  <last_update_submitted>June 17, 2021</last_update_submitted>
  <last_update_submitted_qc>June 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

